Analyst Coverage
Analyst Coverage
The following research analysts cover Destiny Pharma.
| Mark Brewer, finnCap | +44(0)20 7220 0500 |
| Andy Smith, Equity Development | +44(0)20 7065 2690 |
| Karl Keegan, Singer Capital Markets | +44(0)20 7496 3187 |
| Brian White, Shore Capital | +44(0)20 7408 4050 |
Please click on links below to access coverage published:
 |
finnCap
Analyst research from finnCap can be obtained by registering on the link above 27 February 2023 – NTCD-M3 US partnering deal and fundraise: value inflection |
 |
Equity Development
20 March 2023 – Onwards and upwards |
 |
Proactive Investors
For further commentary and interviews, please visit the Destiny Pharma page at Proactive Investors on the link above |
 |
VOX Markets
For further commentary and interviews, please visit the Destiny Pharma page at Vox Markets on the link above |